286 related articles for article (PubMed ID: 20685651)
21. Molecular basis of the acceleration of the GDP-GTP exchange of human ras homolog enriched in brain by human translationally controlled tumor protein.
Dong X; Yang B; Li Y; Zhong C; Ding J
J Biol Chem; 2009 Aug; 284(35):23754-64. PubMed ID: 19570981
[TBL] [Abstract][Full Text] [Related]
22. mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging.
Yadav RB; Burgos P; Parker AW; Iadevaia V; Proud CG; Allen RA; O'Connell JP; Jeshtadi A; Stubbs CD; Botchway SW
BMC Cell Biol; 2013 Jan; 14():3. PubMed ID: 23311891
[TBL] [Abstract][Full Text] [Related]
23. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.
Alam H; Maizels ET; Park Y; Ghaey S; Feiger ZJ; Chandel NS; Hunzicker-Dunn M
J Biol Chem; 2004 May; 279(19):19431-40. PubMed ID: 14982927
[TBL] [Abstract][Full Text] [Related]
24. Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR.
Wagner RJ; Martin KA; Powell RJ; Rzucidlo EM
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C119-27. PubMed ID: 20375271
[TBL] [Abstract][Full Text] [Related]
25. Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.
Lu ZH; Shvartsman MB; Lee AY; Shao JM; Murray MM; Kladney RD; Fan D; Krajewski S; Chiang GG; Mills GB; Arbeit JM
Cancer Res; 2010 Apr; 70(8):3287-98. PubMed ID: 20388784
[TBL] [Abstract][Full Text] [Related]
26. Rheb protein binds CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase) protein in a GTP- and effector domain-dependent manner and influences its cellular localization and carbamoyl-phosphate synthetase (CPSase) activity.
Sato T; Akasu H; Shimono W; Matsu C; Fujiwara Y; Shibagaki Y; Heard JJ; Tamanoi F; Hattori S
J Biol Chem; 2015 Jan; 290(2):1096-105. PubMed ID: 25422319
[TBL] [Abstract][Full Text] [Related]
27. The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis.
Kang YJ; Lu MK; Guan KL
Cell Death Differ; 2011 Jan; 18(1):133-44. PubMed ID: 20616807
[TBL] [Abstract][Full Text] [Related]
28. Phospholipase D1 is an effector of Rheb in the mTOR pathway.
Sun Y; Fang Y; Yoon MS; Zhang C; Roccio M; Zwartkruis FJ; Armstrong M; Brown HA; Chen J
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8286-91. PubMed ID: 18550814
[TBL] [Abstract][Full Text] [Related]
29. Structural basis for the unique biological function of small GTPase RHEB.
Yu Y; Li S; Xu X; Li Y; Guan K; Arnold E; Ding J
J Biol Chem; 2005 Apr; 280(17):17093-100. PubMed ID: 15728574
[TBL] [Abstract][Full Text] [Related]
30. MCRS1 binds and couples Rheb to amino acid-dependent mTORC1 activation.
Fawal MA; Brandt M; Djouder N
Dev Cell; 2015 Apr; 33(1):67-81. PubMed ID: 25816988
[TBL] [Abstract][Full Text] [Related]
31. The Rheb switch 2 segment is critical for signaling to target of rapamycin complex 1.
Long X; Lin Y; Ortiz-Vega S; Busch S; Avruch J
J Biol Chem; 2007 Jun; 282(25):18542-18551. PubMed ID: 17470430
[TBL] [Abstract][Full Text] [Related]
32. Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1).
Ge Y; Yoon MS; Chen J
J Biol Chem; 2011 Oct; 286(41):35675-35682. PubMed ID: 21852229
[TBL] [Abstract][Full Text] [Related]
33. Lysosomal accumulation of mTOR is enhanced by rapamycin.
Ohsaki Y; Suzuki M; Shinohara Y; Fujimoto T
Histochem Cell Biol; 2010 Dec; 134(6):537-44. PubMed ID: 21063721
[TBL] [Abstract][Full Text] [Related]
34. The late endosome is essential for mTORC1 signaling.
Flinn RJ; Yan Y; Goswami S; Parker PJ; Backer JM
Mol Biol Cell; 2010 Mar; 21(5):833-41. PubMed ID: 20053679
[TBL] [Abstract][Full Text] [Related]
35. The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.
Codeluppi S; Svensson CI; Hefferan MP; Valencia F; Silldorff MD; Oshiro M; Marsala M; Pasquale EB
J Neurosci; 2009 Jan; 29(4):1093-104. PubMed ID: 19176818
[TBL] [Abstract][Full Text] [Related]
36. The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity.
Basso AD; Mirza A; Liu G; Long BJ; Bishop WR; Kirschmeier P
J Biol Chem; 2005 Sep; 280(35):31101-8. PubMed ID: 16006564
[TBL] [Abstract][Full Text] [Related]
37. Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease.
Pryor WM; Biagioli M; Shahani N; Swarnkar S; Huang WC; Page DT; MacDonald ME; Subramaniam S
Sci Signal; 2014 Oct; 7(349):ra103. PubMed ID: 25351248
[TBL] [Abstract][Full Text] [Related]
38. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.
Long X; Ortiz-Vega S; Lin Y; Avruch J
J Biol Chem; 2005 Jun; 280(25):23433-6. PubMed ID: 15878852
[TBL] [Abstract][Full Text] [Related]
39. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
[TBL] [Abstract][Full Text] [Related]
40. Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex.
Yasuda S; Sugiura H; Katsurabayashi S; Shimada T; Tanaka H; Takasaki K; Iwasaki K; Kobayashi T; Hino O; Yamagata K
Sci Rep; 2014 Jun; 4():5155. PubMed ID: 24889507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
